iCan, a new commercial stage, innovative glucose monitor. The science to date including USA and Chinese clinical experience.

Sinocare Meditech Inc. |

Chairs: Lutz Heinemann (GER), Thomas Haak (GER)

13:00 – 13:05Welcome and introductionAll chairs
13:05 – 13:10Sinocare Meditech: committed to innovation in CGM technologyJiangfeng Fei (USA)
13:10 – 13:25iCan CGM: performance data and patient experience insights from the Chinese clinical experienceLinong Ji (CHN)
13:25 – 13:40A pilot study of the feasibility and accuracy of the iCan CGM system – effect of interferentsRon Brazg (USA)
13:40 – 13:55Understanding the T2DM experience: a new challenge for CGM systems?Thomas Haak (GER)
13:55 – 14:00Q&AAll chairs